FMC Corporation FMC reported a loss of 12 cents per share for first-quarter 2025. This compares unfavorably to loss of 2 cents incurred in the year-ago quarter. Barring one-time items, adjusted earnings per share were 18 cents, beating the Zacks Consensus Estimate of 8 cents. Revenues were $791.4 million in the quarter, down around 13.8% from the year-ago quarter’s levels. The top line beat the Zacks Consensus Estimate of $779 million. The top line fell due to a price decline of 9%, more than half of which was related to price adjustments in certain contracts with specific diamide partners. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) FMC Corporation Price, Consensus and EPS Surprise FMC Corporation price-consensus-eps-surprise-chart | FMC Corporation Quote FMC’s Regional Sales Performance In North America, sales tumbled 28% year over year to $186 million in the quarter on reduced volumes. The figure missed the consensus estimate of $224.2 million. The decline was primarily due to lower volumes as customers in the United States delayed purchases as anticipated, which was exacerbated by international trade dynamics. Latin American sales saw a 10% year-over-year rise to $207 million in the reported quarter. It beat the consensus estimate of $137.9 million. Volume grew due to increasing direct sales to cotton growers in Brazil, as well as product-on-the-ground sales surpassing FMC sales into the channel. In Asia, revenues declined 24% from the prior-year quarter to $125 million. It lagged the consensus estimate of $144.8 million. Prudent selling to allow channel destocking led to lower volumes. EMEA sales fell 11% year over year to $273 million in the reported quarter. It missed the consensus estimate of $278.5 million. EMEA sales are being adversely impacted by lower volumes, including the expected loss of registration for triflusulfuron. FMC’s Financials The company had cash and cash equivalents of $315.3 million at the end of the quarter, down roughly 11.8% sequentially. Long-term debt was $3,027.7 million, flat sequentially. FMC’s Guidance The company has maintained its revenue outlook for the year at $4.15 billion to $4.35 billion, which is essentially flat compared to the prior year at the midpoint. The adjusted EBITDA forecast also remains unchanged at $870 million to $950 million, implying a 1% increase at the midpoint from the prior year, or a 4% increase when excluding the GSS divestiture impact. This guidance includes estimated incremental tariff costs of $15 million to $20 million, based on the latest government guidelines. The company has also reiterated its adjusted earnings per diluted share outlook of $3.26 to $3.70, which is flat at the midpoint compared to the previous year. Additionally, the free cash flow forecast remains at $200 million to $400 million. Story Continues FMC’s Price Performance FMC’s shares have lost 30.8% in the past year compared with a 9.6% decline of the industry.Zacks Investment Research Image Source: Zacks Investment Research FMC’s Zacks Rank & Key Picks FMC currently carries a Zacks Rank #3 (Hold). Better-ranked stocks worth a look in the basic materials space include Hawkins, Inc. HWKN, SSR Mining Inc. SSRM and Intrepid Potash, Inc. IPI. While HWKN carries a Zacks Rank #1 (Strong Buy), SSRM and IPI carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Hawkins is expected to report fiscal fourth-quarter results on May 21. The consensus estimate for Hawkins’ earnings is pegged at 74 cents. HWKN beat the consensus estimate in one of the last four quarters while missing thrice, with the average earnings surprise being 6.1%. SSRM is scheduled to release first-quarter results on May 6. The Zacks Consensus Estimate for SSRM’s first-quarter earnings is pegged at 8 cents. SSRM has a trailing four-quarter earnings surprise of 155.7%, on average. Intrepid Potash is slated to release first-quarter results on May 5. The consensus estimate for IPI’s first-quarter loss is 12 cents, stable over the past 60 days. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC):Free Stock Analysis Report Intrepid Potash, Inc (IPI):Free Stock Analysis Report Silver Standard Resources Inc. (SSRM):Free Stock Analysis Report Hawkins, Inc. (HWKN):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
FMC Corp's Earnings and Revenues Surpass Estimates in Q1
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...